This inventor holds 2 USPTO granted patents and 2 EPO patents. Top assignee: Council of Scientific and Industrial Research. Active years: 2016.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
Years Active: 2016
Title: Innovations in Glioma Therapy by Somasundaram Kumaravel
Introduction
Somasundaram Kumaravel is an accomplished inventor based in Bengaluru, India. He has made significant contributions to the field of glioma therapy, focusing on innovative approaches to improve patient outcomes. With a total of 2 patents, his work is paving the way for advancements in cancer treatment.
Latest Patents
Kumaravel's latest patents include groundbreaking inventions aimed at enhancing the treatment of glioblastoma, a highly aggressive form of brain cancer. One of his notable inventions is titled "TOP2A inhibition by temozolomide and its predictive value of GBM patients survival." This invention demonstrates that temozolomide acts as a TOP2A inhibitor, which can predict the survival of glioblastoma patients. The findings indicate that patients with higher TOP2A transcript levels have a better prognosis, thus establishing a new prognostic indicator for those undergoing temozolomide chemotherapy.
Another significant patent is related to the "Nicotinamide phosphoribosyltransferase (NMPRTase) inhibitor for glioma therapy." This invention identifies a compound that inhibits NMPRTase, which is crucial for glioma cell growth. Through a structure-based drug discovery approach, Kumaravel's research has led to the identification of potential ligands that can effectively inhibit glioma cell viability, showcasing the potential for novel therapeutic options in glioblastoma treatment.
Career Highlights
Kumaravel is associated with the Council of Scientific and Industrial Research, where he continues to contribute to innovative research in cancer therapy. His work is characterized by a commitment to improving the lives of patients suffering from glioblastoma through scientific advancements.
Collaborations
Kumaravel has collaborated with notable colleagues, including Nagasuma Chandra and Arivazhagan Arimappamagan. These collaborations have further enriched his research and contributed to the development of effective therapies for glioma.
Conclusion
Somasundaram Kumaravel's innovative work in glioma therapy exemplifies the potential of scientific research to transform cancer treatment. His patents not only provide insights into the mechanisms of glioblastoma but also offer hope for improved patient survival rates.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile